Viewing Study NCT06854094


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-01-03 @ 7:15 AM
Study NCT ID: NCT06854094
Status: RECRUITING
Last Update Posted: 2025-03-03
First Post: 2025-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Consolidation Therapy with Cladribine in Relapsing Multiple Sclerosis Patients
Sponsor: Ente Ospedaliero Cantonale, Bellinzona
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: OCR_CLAD INSI.SM.2403
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View